Search
for
Sort by
Research 361–390 of 777
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- The JAK/STAT signaling pathway: from bench to clinic
- Alopecia Areata: An Updated Review for 2023
- Alopecia Areata: Current Treatments and New Directions
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Mechanisms of autophagy and their implications in dermatological disorders
- Immune therapies for alopecia areata: evidence and new perspectives
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Alopecia Areata: Current and Emerging Therapies
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Resident Memory T Cells in Autoimmune Skin Diseases
- Treatment of pediatric alopecia areata: A systematic review
- New and Emerging Therapies for Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Treating Alopecia Areata: Current Practices Versus New Directions
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Alopecia Areata: Clinical Treatment
- New Modalities in the Treatment of Refractory Alopecia Areata